Brought to you by 
Siemens buys into clinical diagnostics in $7bn Dade takeover
25 Jul 2007
Executive Summary
Siemens AG plans to make a tender offer to buy clinical diagnostics specialist Dade Behring for $77 in cash per share (a 36% premium), valuing the acquisition at $7bn or four times Dade's 2006 revenues.
Deal Industry
- In Vitro Diagnostics
-
In Vitro Diagnostics
- Chemistry, Immunoassay
- Hematology, Coagulation
- Therapeutic Drug Monitoring
Deal Status
- Final
Deal Type
-
Acquisition
- Full Acquisition
- Payment Includes Cash
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com